Data for GAW20: genome-wide DNA sequence variation and epigenome-wide DNA methylation before and after fenofibrate treatment in a family study of metabolic phenotypes

Table 2 Demographic and clinical characteristics of GAW20 participants

	Mean/median (SD/IQR)	N
Female, n (%)	576 (52.1)	1105
Age, years^a	48.2 (16.3)	1105
Center, n (%):		1105
Minnesota	565 (51.1)
Utah	540 (48.9)
TGsvisit 1, mg/dL^b	119 (79;180)	802
TGsvisit 2, mg/dL^b	109 (73;171)	1103
TGsvisit 3, mg/dL^b	75.0 (53;112)	625
TGsvisit 4, mg/dL^b	75.0 (53;108)	818
HDL-cholesterol visit 1, mg/dL^a	46.5 (13.2)	802
HDL-cholesterol visit 2, mg/dL^a	47.2 (13.1)	1104
HDL-cholesterol visit 3, mg/dL^a	49.3 (13.4)	793
HDL-cholesterol visit 4, mg/dL^a	49.4 (13.5)	861
Smoking, n (%):		1104
Never smoker	780 (70.7)
Past smoker	239 (21.6)
Current smoker	85 (7.7)
NCEP/ATP diagnosis of metabolic syndrome, n (%)	418 (37.8)	1105
IDF diagnosis of metabolic syndrome, n (%)	458 (41.4)	1105

ISSN: 1753-6561